000057645 001__ 57645
000057645 005__ 20190625110921.0
000057645 0247_ $$2pmid$$apmid:9191672
000057645 0247_ $$2DOI$$a10.1007/s00339-006-3494-3
000057645 0247_ $$2WOS$$aWOS:000236641800022
000057645 0247_ $$2ISSN$$a0947-8396
000057645 0247_ $$2altmetric$$aaltmetric:21817417
000057645 037__ $$aPreJuSER-57645
000057645 041__ $$aeng
000057645 082__ $$a530
000057645 084__ $$2WoS$$aMaterials Science, Multidisciplinary
000057645 084__ $$2WoS$$aPhysics, Applied
000057645 1001_ $$0P:(DE-HGF)0$$aHalder, S.$$b0
000057645 245__ $$aStructural, dielectric and electrochemical study of Hf-substituted BaTiO3 thin films fabricated by CSD
000057645 260__ $$aBerlin$$bSpringer$$c2006
000057645 300__ $$a285 - 288
000057645 3367_ $$0PUB:(DE-HGF)16$$2PUB:(DE-HGF)$$aJournal Article
000057645 3367_ $$2DataCite$$aOutput Types/Journal article
000057645 3367_ $$00$$2EndNote$$aJournal Article
000057645 3367_ $$2BibTeX$$aARTICLE
000057645 3367_ $$2ORCID$$aJOURNAL_ARTICLE
000057645 3367_ $$2DRIVER$$aarticle
000057645 440_0 $$0560$$aApplied Physics A$$v83$$x0947-8396$$y2
000057645 500__ $$aRecord converted from VDB: 12.11.2012
000057645 520__ $$aThe immune environment of human soft-tissue injury is unstudied. We studied fracture soft-tissue hematomas (FxSTH) in 56 patients with high-energy bony fractures. FxSTH serum and mononuclear cells (MNC) as well as fracture patient plasma and blood MNC were studied. Twenty healthy controls donated plasma and MNC. Soluble tumor necrosis factor (TNF)-alpha, interleukin (IL-1 beta, IL-2, 6, 8, 10, 12, and interferon-gamma were studied by enzyme linked immunosorbent assay. Cells were studied by flow cytometry after cell-membrane stains for CD-14, TNF-alpha (mTNF), and human leukocyte antigen-DR, or intracellular stains for TNF (icTNF) and IL-10. Thirty-six patients with Injury Severity Score < 15 were analyzed further to evaluate the effects of isolated fracture on systemic immunity. Cytokines were rarely detectable in control plasma. TNF-alpha, IL-1 beta, IL-2, and interferon-gamma were rarely found in FxSTH serum or fracture patient plasma. All FxSTH sera were rich in IL-6, peaking before 48 hours (12,538 +/- 4,153 vs. 3,494 +/- 909 pg/mL, p = 0.02, U test). In Injury Severity Score < 15, IL-6 was not detectable in most early fracture patient plasma, but rose after 48 hours (p = 0.028). FxSTH serum IL-8 peaked after 48 hours (440 +/- 289 vs. 4,542 +/- 1,219 pg/mL, p = 0.006) and circulating IL-8 appeared after 72 hours. IL-6 and IL-8 showed gradients from FxSTH serum to paired PtS (p < 0.05, Wilcoxon). IL-10 was abundant (884 +/- 229 pg/mL) in FxSTH serum < 24 hours old. FxSTH serum IL-12 peaked late (3,323 +/- 799 pg/mL, day 4-7) then fell (p < 0.001, analysis of variance). Only IL-12 was higher in fracture patient plasma (1,279 +/- 602 pg/mL) than FxSTH serum (591 +/- 327 pg/mL) during the first 48 hours (p = 0.032, U test). On flow cytometry, control monocytes expressed 201 +/- 31 mTNF sites/cell, but icTNF was absent. mTNF was up-regulated after injury more in FxSTH monocytes (3,202 +/- 870 sites/cell) than peripheral blood monocytes (584 +/- 186 sites/cell) (p < 0.05 vs. peripheral blood monocytes by Wilcoxon, p < 0.001 vs. control monocytes by U test). Intracellular IL-10 was abundant in all MNC, but varied widely after injury. Fracture and peripheral blood monocytes expressed far less human leukocyte antigen-DR than control monocytes. Fractures create an inflammatory local environment. Proximal mediators are cell-associated and relatively confined to the wound, but soluble IL-6, IL-8, and IL-10 are abundant and probably exported. Systemic MNC have complex responses to local injuries. These may reflect the combined impact of multiple soluble cytokines initially generated within the wound. FxSTH appear to be a potentially important source of immunomodulatory cytokines in trauma.
000057645 536__ $$0G:(DE-Juel1)FUEK414$$2G:(DE-HGF)$$aKondensierte Materie$$cP54$$x0
000057645 588__ $$aDataset connected to Web of Science, Pubmed
000057645 650_2 $$2MeSH$$aAdolescent
000057645 650_2 $$2MeSH$$aAdult
000057645 650_2 $$2MeSH$$aAged
000057645 650_2 $$2MeSH$$aAged, 80 and over
000057645 650_2 $$2MeSH$$aAnalysis of Variance
000057645 650_2 $$2MeSH$$aCase-Control Studies
000057645 650_2 $$2MeSH$$aCytokines: blood
000057645 650_2 $$2MeSH$$aFemale
000057645 650_2 $$2MeSH$$aFractures, Bone: complications
000057645 650_2 $$2MeSH$$aFractures, Bone: immunology
000057645 650_2 $$2MeSH$$aHLA-DR Antigens: blood
000057645 650_2 $$2MeSH$$aHematoma: complications
000057645 650_2 $$2MeSH$$aHematoma: immunology
000057645 650_2 $$2MeSH$$aHumans
000057645 650_2 $$2MeSH$$aImmunity, Cellular
000057645 650_2 $$2MeSH$$aMale
000057645 650_2 $$2MeSH$$aMiddle Aged
000057645 650_2 $$2MeSH$$aMonocytes: immunology
000057645 650_2 $$2MeSH$$aSoft Tissue Injuries: complications
000057645 650_2 $$2MeSH$$aSoft Tissue Injuries: immunology
000057645 650_2 $$2MeSH$$aTime Factors
000057645 650_7 $$00$$2NLM Chemicals$$aCytokines
000057645 650_7 $$00$$2NLM Chemicals$$aHLA-DR Antigens
000057645 650_7 $$2WoSType$$aJ
000057645 7001_ $$0P:(DE-HGF)0$$aGerber, P.$$b1
000057645 7001_ $$0P:(DE-HGF)0$$aSchneller, T.$$b2
000057645 7001_ $$0P:(DE-Juel1)131022$$aWaser, R.$$b3$$uFZJ
000057645 773__ $$0PERI:(DE-600)1398311-8$$a10.1007/s00339-006-3494-3$$gVol. 83, p. 285 - 288$$p285 - 288$$q83<285 - 288$$tApplied physics / A$$v83$$x0947-8396$$y2006
000057645 8567_ $$uhttp://dx.doi.org/10.1007/s00339-006-3494-3
000057645 909CO $$ooai:juser.fz-juelich.de:57645$$pVDB
000057645 9131_ $$0G:(DE-Juel1)FUEK414$$bMaterie$$kP54$$lKondensierte Materie$$vKondensierte Materie$$x0$$zentfällt   bis 2009
000057645 9141_ $$aNachtrag$$y2006
000057645 915__ $$0StatID:(DE-HGF)0010$$2StatID$$aJCR/ISI refereed
000057645 915__ $$0StatID:(DE-HGF)0100$$2StatID$$aJCR
000057645 915__ $$0StatID:(DE-HGF)0111$$2StatID$$aWoS$$bScience Citation Index Expanded
000057645 915__ $$0StatID:(DE-HGF)0150$$2StatID$$aDBCoverage$$bWeb of Science Core Collection
000057645 915__ $$0StatID:(DE-HGF)0199$$2StatID$$aDBCoverage$$bThomson Reuters Master Journal List
000057645 915__ $$0StatID:(DE-HGF)0300$$2StatID$$aDBCoverage$$bMedline
000057645 9201_ $$0I:(DE-Juel1)VDB321$$d31.12.2006$$gIFF$$kIFF-IEM$$lElektronische Materialien$$x1
000057645 9201_ $$0I:(DE-Juel1)VDB381$$d14.09.2008$$gCNI$$kCNI$$lCenter of Nanoelectronic Systems for Information Technology$$x2$$z381
000057645 9201_ $$0I:(DE-82)080009_20140620$$gJARA$$kJARA-FIT$$lJülich-Aachen Research Alliance - Fundamentals of Future Information Technology$$x3
000057645 970__ $$aVDB:(DE-Juel1)90676
000057645 980__ $$aVDB
000057645 980__ $$aConvertedRecord
000057645 980__ $$ajournal
000057645 980__ $$aI:(DE-Juel1)PGI-7-20110106
000057645 980__ $$aI:(DE-Juel1)VDB381
000057645 980__ $$aI:(DE-82)080009_20140620
000057645 980__ $$aUNRESTRICTED
000057645 981__ $$aI:(DE-Juel1)PGI-7-20110106
000057645 981__ $$aI:(DE-Juel1)VDB381
000057645 981__ $$aI:(DE-Juel1)VDB881